Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL
Clinical trial NCT04499573 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04499573
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2022-03-13
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.